Topic Listing for ABAXIS

Abaxis Inc Index Exhibits Abaxis Inc Notice Grant Restricted Stock Units
Abaxis Inc Report Form 10-q 2004 Table Contents Abaxis Inc Schedule Valuation Qualifying Accounts Reserves 2008
Abaxis Reports Record Financial Results 2006 Adjustment Provisions
Administration Amersham Biosciences Corp Formerly Pharmacia Biotech Inc
Annual Cash Incentive Bonus Approval Amendment 2005 Equity Incentive Plan
Asia Latin America Attend Annual Meeting
Attestation Report Independent Registered Public Accounting Firm Audit Committee
Audit Committee Pre-approval Permissible Non-audit Services Independent Auditors Base Salary
Basis Presentation Becton Dickinson
Beneficial Owner Shares Registered Name Broker Bank Beneficial Ownership Reporting Compliance
Board Directors Unanimously Recommends Vote Nominees Named Above Business Overview
Canine Heartworm Rapid Test Cash Compensation Paid Board Members
Cash Flow Changes Cash Flow Impact
Cash-based Awards Other Stock-based Ceo Cfo Certifications
Ceo Employment Agreement Certain Relationships Related Party Transactions
Certain Relationships Related Transactions Certification Chief Executive Officer
Certification Chief Financial Officer Change Control Agreements
Change Control Arrangements Change Control Benefits
Change Independent Auditors Change Vote After Submitting Proxy
Changes Internal Control Over Financial Reporting Changes Party Payor Reimbursement Regulations Negatively Affect Business
Changes Registrants Certifying Accountant Changes Third-party Payor Reimbursement Regulations Negatively Affect Business
Clinical Laboratory Improvements Act Regulations Clinton Severson Abaxis Inc Chairman Ceo Santa Ines
Coagulation Code Business Conduct Ethics
Commitments Contingencies Committee Charters Other Corporate Governance Materials
Communications Directors Compared 2005
Comparison Cumulative Total Return Among Abaxis Inc Russell Comparison Revenues 2003 2004
Comparison Shareholder Return Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Processes Procedures
Compensation Committee Report Compensation Determinations
Compensation Directors Compensation Discussion Analysis
Compete Larger Better Established Entities Such Hospitals Commercial Competition
Competitive Benchmarking Comply Strict Potentially Costly Environmental Regulations
Comply Strict Potentially Costly Environmental Regulations Pay Significant Comprehensive Income
Conclusion Regarding Effectiveness Disclosure Controls Procedures Consent Independent Registered Public Accounting Firm
Contingencies Continue Develop Marketing Distribution Experience Human Diagnostic Market
Continue Develop Sales Marketing Distribution Experience Human Diagnostic Contractual Obligations
Corporate Governance Committees Cost Product Sales
Cost Revenues Critical Accounting Policies
Current Report Pursuant Securities Exchange Act 1934 Customers
Customers Distribution Date Report Earliest Event Reported
Date Report Earliest Event Reported 2006 Deductibility Executive Compensation
Deferred Compensation Awards Definitions
Depend Key Members Management Scientific Staff Fail Retain Depend Key Members Management Scientific Staff Retain Recruit
Depend Limited Sole Suppliers Several Key Components Products Depend Sole Suppliers Several Key Components Products Not
Dependent Profitability Cannot Remain Profitable Need Additional Funding Description Business Significant Accounting Policies
Development Licensing Revenue Diatron Messtechnik Gmbh
Director Attendance Annual Meetings Director Compensation Table
Directors Executive Officers Registrant Disclaimer
Disclosure Controls Internal Distribution Outside North America
Distribution Within North America Dividend Policy
Dividends Duration Amendment Termination
Dvm Resources Effect Certain Corporate Events
Effectively Train Integrate Members Sales Team Order Achieve Effects Clinical Laboratory Improvement Amendments Products
Election Directors Eligibility
Employees Employment Agreement
Employment Agreements Entry Material Definitive Agreement
Equity Compensation Information Equity Compensation Paid Board Members
Equity Compensation Plan Information Equity Compensation Plans
Establishment Plan Europe
Evaluation Disclosure Controls Procedures Exact Name Registrant Specified Charter
Executive Change Control Severance Plan Executive Compensation Other Matters
Executive Compensation Policies 2006 Executive Compensation Policies 2007
Executive Compensation Program Objectives Framework Exhibits
Facilities Manufacturing Operations Vulnerable Natural Disasters Other Unexpected Fail Achieve Anticipated Revenue Experience Problems Related Manufacture
Fail Achieve Anticipated Revenue Market Not Accept Products Fail Achieve Anticipated Revenue Problems Related Manufacture New
Federal Income Tax Information Fin
Financial Condition Financial Statements Exhibits
Financing Activities Find Out Results Voting Annual Meeting
Fluctuations Foreign Exchange Rates Possible Lack Financial Stability Food Drug Administration Clearance
Foreign Currency Rate Fluctuations Form 10-k
Form 10-q Forward-looking Statements
Future Products General
General Administrative General Information
George Hashburger Kensington Management Analyst Government Regulation
Grant Restricted Stock Units 2007 Gross Profit
Gross Profit Medical Market Segment Gross Profit Veterinary Market Segment
Held 2006 Held 2007
Held 2008 Held 2009
Hematology Henry Schein
Householding Proxy Materials Identification Audit Committee Financial Expert
Impact Adoption Fas 123 Financial Results Impact Adoption Sfas 123 Financial Results
Inadvertently Produce Defective Products Subject Significant Warranty Liabilities Incentive Plans
Income Tax Provision Income Tax Provision Benefit
Income Taxes Increase Sales Piccolo Vetscan Products Not Able Maintain
Increase Sales Piccolo Vetscan Products Not Able Profitability Incurred Continue Incur Future Periods Significant Share-based Compensation
Indemnification Agreements Independence Board Directors
Independent Auditors Index Consolidated Financial Statements
Index Exhibits Index Financial Statements
Industry Vitro Diagnostic Testing Information Available Investors
Information Regarding Committees Board Directors Instruments
Interest Expense Other Income Net Interest Income
Interest Other Expense Interest Other Income
Interest Other Income Expense Net Interest Other Net
Interest Rate Risk Introduction
Inventories Inventories Net
Inventory Investing Activities
James Sidoti Analyst Joe Diaz Rcg Capital Markets Group
Legislative Actions Higher Insurance Cost Potential New Accounting Line Credit
Liquidity Capital Resources Long-term Equity Incentive Compensation
Managements Report Internal Control Over Financial Reporting Manufacturing
Market Information Common Stock Material Relationships Suppliers Other Parties
Medical Market Medical Market Results
Meetings Board Directors Meetings Related Governance Matters
Miscellaneous Need Additional Funding Future Funds Not Available
Need Comply Manufacturing Regulations Need Fda Certification Medical Device Products
Need Successfully Manufacture Market Additional Reagent Discs Human Net Income Per Share
New Independent Registered Public Accounting Firm Nine-month Results
Nominating Corporate Governance Committee Nominees
Not Able Compete Effectively Larger Better Established Entities Not Able Compete Effectively Larger Established Entities Products
Not Able Compete Larger Better Established Entities Products Not Able Compete Organizations Products Future
Not Able Predict Sales Future Number Factors Affect Not Applicable Exhibits
Not Been Consistently Profitable Increase Sales Piccolo Vetscan Number 000-19720
Only Recently Become Consistently Profitable Increase Sales Piccolo Operating Activities
Operating Results Materially Affected Unanticipated Changes Tax Provisions Option Exercises 2006 Values
Option Exercises Stock Vested 2007 Option Exercises Stock Vested 2008
Option Exercises Stock Vested 2009 Options Exercised
Orbos Process Other
Other Compensation Benefits Other Matters
Other Regulations Overview
Part Participants 2006
Participating Employers Patents Proprietary Technologies
Paying Proxy Solicitation Performance Awards
Piccolo System Planned Remediation Action Address Material Weakness Internal Control
Point-of-care Blood Chemistry Analyzer Point-of-care Blood Chemistry Analyzers
Potential New Accounting Pronouncements Impact Future Financial Position Pre-approval Policies Procedures
Preferred Dividends Preferred Dividends Accretion
President Chief Executive Officer Compensation Previous Independent Registered Public Accounting Firm
Price Range Common Stock Principal Accountant Fees Services
Pro Forma Information Periods Prior Adoption Sfas 123 Proposal Election Directors
Proposal Number Proxy Statement Annual Meeting Shareholders
Ption Ranted Iscal 2005 Ption Xercises Iscal 2005 Alues Arch
Purchase Commitments Purpose
Quarterly Results Question Answer
Quorum Present Voting Nominees Receiving Highest Number Votes Ratification Selection Independent Registered Public Accounting Firm
Reagent Discs Reagent Discs Kits
Receiving Materials Recent Accounting Pronouncements
Redeemable Convertible Preferred Stock Series Registered Public Accounting Firm
Registrants Telephone Number Including Area Code 510 675-6500 Registrants Telephone Number Including Area Code Securities Registered
Related-person Transactions Policy Procedures Rely Distributors Sell Products Sole Distributor Arrangements Number
Rely Patents Other Proprietary Information Loss Negatively Affect Rely Primarily Distributors Sell Products Sole Distributor Arrangements
Report Audit Committee Report Audit Committee Board Directors
Report Compensation Committee Executive Report Independent Registered Public Accounting Firm
Report Independent Registered Public Accounting Firm Internal Controls Research Development
Research Development Expense Reserves Accruals
Restricted Stock Unit Activity Restricted Stock Units
Result New Requirements Relating Accounting Treatment Employee Stock Results
Results Operations Financial Condition Revenue Information
Revenue Recognition Revenues Customer Group
Revenues Geographical Location Revenues Medical Market Segment
Revenues Product Category Customer Group Geographic Region Significant Revenues Veterinary Market Segment
Risk Factors Affect Performance Role Compensation Committee
Ron Stevens Ruby Fund Analyst Sab 108
Sales Force Been Employed Less Effectively Train Integrate Sales Marketing
Santa Ines Abaxis Inc Cfo Sarbanes-oxley 302 Certification
Scil Animal Care Gmbh Securities Authorized Issuance Equity Compensation Plans
Selling General Administrative Expense Separation Benefits
Sfas 123 Sfas 157
Shareholder Communications Board Directors Shareholder Proposals Due Next Annual Meeting
Shareholder Proposals Presented Next Annual Meeting Shareholder Record Shares Registered Name
Shareholders Equity Shareholders Rights Plan Ability Issue Preferred Stock Delay
Shares Subject 2005 Plan Signatures
Significant Concentrations Standards Compliance 404 Sarbanes-oxley Act 2002 Complex Unable
Standards Compliance 404 Sarbanes-oxley Act 2002 Uncertain Fail Stock Option Acceleration
Stock Option Exercises Stock Option Exercises 2006
Stock Option Grants Stock Option Grants 2006
Stock Options Stock Performance Graph
Stock Price Highly Volatile Investing Involves High Degree Stock Purchase Rights
Subject Increasingly Complex Requirements Recent Legislation Requiring Companies Subject Numerous Governmental Regulations
Subject Numerous Governmental Regulations Regulatory Changes Difficult Predict Successor
Summary Significant Accounting Policies System Failures Delays Harm Business Facilities Manufacturing Operations
Table Contents Tax Considerations
Tax Effects Stock Awards Term Number Directors
Terms Options Terms Restricted Stock Awards
Terms Restricted Stock Unit Awards Terms Stock Appreciation Rights
Tilton Gardner Brooks Street Securities Analyst Todd Bailey Kane Anderson Analyst
Todd Bailey Kane Anderson Analyst Ataliente Alliance Capital Union City California
United States Valuation Expense Recognition Method Restricted Stock Unit
Valuation Expense Recognition Method Stock Options Vedco Inc
Veterinary Market Veterinary Market Results
Vetscan Dxs Vote
Vote Annual Meeting Vote Required Board Directors Recommendation
Vote Required Each Proposal Vote Required Recommendation Board Directors
Votes Votes Counted
Votes Needed Approve Each Proposal Voting Telephone Via Internet
Warranty Reserves What Another Matter Properly Brought Before Meeting
What Broker Non-votes What Mean Receive Proxy Card
What Mean Receive Set Proxy Materials What Proxy Materials Available Internet
What Quorum Requirement What Return Proxy Card Not Make Specific Choices
What Voting 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki